Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression

Cisplatin resistance is a main clinical problem of lung cancer therapy. Gambogic acid (GA) could prohibit the proliferation of a variety of human cancer cells. However, the effects of GA on cisplatin-resistant lung cancer are still unclear. The objective of the present study was to find out the anti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Zhang, Wendian, Zhou, Hechao, Yu, Ying, Li, Jingjing, Li, Haiwen, Jiang, Danxian, Chen, Zihong, Yang, Donghong, Xu, Zumin, Yu, Zhonghua
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4898431/
https://ncbi.nlm.nih.gov/pubmed/27330316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S100936
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados